|
No. |
Topic |
Summary |
Pages |
8154
| ICH Q8 Step 2 - Pharmaceutical Development | - | 33 |
8155
| Risk Management - Relevance in Development | - | 27 |
8156
| Chemical Process Development - How Much GMP in What Phase | - | 23 |
8157
| GMP Aspects During Formulation Development | - | 25 |
8158
| 'Design space' - The opportunity for Continuous Improvement ? | - | 40 |
8159
| Dossier Requirements for CTD 3.2. P.2 Pharmaceutical DevelopmentPart II - What is relevant for the Licensing Authorities ? | - | 38 |
